Consider Steroids for Some Hospitalized COVID-19 Patients

Questions are flooding in about whether dexamethasone is a “breakthrough” in treating COVID-19.

The buzz is from a U.K. study that suggests dexamethasone reduces mortality in hospitalized patients with severe COVID-19.

This contradicts early guidance to avoid adding steroids for COVID-19...due to lack of benefit and possible harm seen in SARS and MERS.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote